Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of centrally acting drugs. Its structural features make it valuable in creating compounds that modulate neurotransmitter activity, especially in the design of selective reuptake inhibitors. Commonly employed in research settings for developing treatments targeting neurological disorders such as depression, anxiety, and neuropathic pain. The compound's chirality and functional groups allow for precise interactions with biological targets, enhancing drug specificity and efficacy. Also utilized in structure-activity relationship (SAR) studies to optimize pharmacokinetic properties in drug discovery programs.